Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target. | Biomark Res | 2023 | 36859358 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Challenges and optimal strategies of CAR T therapy for hematological malignancies. | Chin Med J (Engl) | 2023 | 36848181 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. | Int J Mol Sci | 2023 | 36835157 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective. | Cells | 2023 | 36831310 | PubTator, text mining | PubMed |
| Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. | Cells | 2023 | 36831248 | PubTator, text mining | PubMed |
| Retinal Pigment Epithelium Cell Development: Extrapolating Basic Biology to Stem Cell Research. | Biomedicines | 2023 | 36830851 | PubTator, text mining | PubMed |
| Circulating biomarkers during progression to type 1 diabetes: A systematic review. | Front Endocrinol (Lausanne) | 2023 | 36817583 | PubTator, text mining | PubMed |
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
| scTenifoldXct: A semi-supervised method for predicting cell-cell interactions and mapping cellular communication graphs. | Cell Syst | 2023 | 36787742 | PubTator, text mining | PubMed |
| The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery. | Int J Mol Sci | 2023 | 36769269 | PubTator, text mining | PubMed |
| The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives. | Int J Mol Sci | 2023 | 36769267 | PubTator, text mining | PubMed |
| DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort. | Int J Mol Sci | 2023 | 36768812 | PubTator, text mining | PubMed |
| Application of Single-Cell and Spatial Omics in Musculoskeletal Disorder Research. | Int J Mol Sci | 2023 | 36768592 | PubTator, text mining | PubMed |
| Remodeling and Restraining Lung Tissue Damage Through the Regulation of Respiratory Immune Responses. | Tissue Eng Regen Med | 2023 | 36763280 | PubTator, text mining | PubMed |
| Quantum modeling of dimethoxyl-indaceno dithiophene based acceptors for the development of semiconducting acceptors with outstanding photovoltaic potential. | RSC Adv | 2023 | 36760314 | PubTator, text mining | PubMed |
| Sepsis-induced changes in differentiation, maintenance, and function of memory CD8 T cell subsets. | Front Immunol | 2023 | 36756117 | PubTator, text mining | PubMed |
| CTCF mediates CD8+ effector differentiation through dynamic redistribution and genomic reorganization. | J Exp Med | 2023 | 36752796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=21